HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR’s 2019 Priorities A Botanical Garden; AHPA To Stay Tuned In

This article was originally published in The Rose Sheet

Executive Summary

The American Herbal Products Association vows to stay abreast of Cosmetic Ingredient Review activities, with ingredients of importance to its members sprinkled throughout the group’s 2019 priority list.

You may also be interested in...



CIR Tackles Growing Natural Workload Against Backdrop Of Widely Held Safety Assumptions

CIR’s Expert Panel reached tentative safe conclusions for a number of naturally derived ingredients at its December meeting, while identifying data deficiencies for others. In his post-meeting report, Executive Director Bart Heldreth highlights recent commentaries in scientific journals defying the notion that natural is necessarily safe and lauding CIR as the preeminent ingredient safety authority.

FDA Proposes Priorities For Cosmetic Ingredient Review: Mica, Probiotics, CBD

Nakissa Sadrieh, director of cosmetics at FDA and the agency’s CIR liaison, floated the three potential review priorities at the CIR Expert Panel’s April 8-9 meeting in Washington. It’s the most for-cause targets proposed by the agency in recent memory, and CIR leadership noted that they pose considerable challenges.

CIR Experts To Take First Look At Brown Algae Ingredients, Strategize For MI/MCI Re-Review

The Cosmetic Ingredient Review’s draft report on brown algae-derived ingredients is up for Expert Panel consideration Sept. 24-25, and five Ginkgo biloba ingredients could receive final safe-as-used sign-off. CIR also seeks the panel’s help in preparing a re-review document for the MI/MCI preservative combination, which is overdue for an updated assessment with usage up significantly since 1992.

Related Content

Topics

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel